A larger study from our group on a cohort of resected primary NSCLCs confirmed these results and further proposed the epigenetic inactivation of KEAP1 by promoter hypermethylation as the main mechanism which leads to reduced or absent Keap1 protein expression previously reported in NSCLC. This evidence concerns the gene KEAP1 and non-small cell lung carcinoma.